Qian, Xiangfeng
Sheng, Yi
Jiang, Yinsheng
Xu, Yongan
Funding for this research was provided by:
General items of Hangzhou Health Science and Technology program (No. B20220306)
Hangzhou government supports science and technology in the development of bio-pharmaceutical and health industries (No. 2021WJCY390)
the National Natural Science Foundation of China (No. 81571916 and 81201478)
Key Research and Development Program of Zhejiang Province (No. 2024C03186)
Major Project of National-Zhejiang Provincial Administration of Traditional Chinese Medicine (No. GZY-ZJ-KJ-24030)
Article History
Received: 2 March 2024
Accepted: 31 May 2024
First Online: 6 June 2024
Declarations
:
: MIMIC-III database was approved by the Institutional Review Boards of Beth Israel Deaconess Medical Center and the Massachusetts Institute of Technology, and informed consent was obtained from each patient. In this study, local institutional review board approval and informed consent were not required because MIMIC research data were publicly available and all patient data were de-identified.
: Not applicable.
: The authors declare no competing interests.